C9047 HCPCS Level II code: Injection, caplacizumab-yhdp, 1 mg
C9047 is the HCPCS code for “Injection, caplacizumab-yhdp, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
C9047Injection, caplacizumab-yhdp, 1 mg
Short description: Injection, caplacizumab-yhdp
HCPCS · United States
Medicare details
The indicators CMS publishes with C9047 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Added
- Jul 1, 2019
Where C9047 sits
- 1C codesOutpatient prospective payment system
- 2Active code C9047Injection, caplacizumab-yhdp, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code C9047 mean?
C9047 is the HCPCS code for “Injection, caplacizumab-yhdp, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover C9047?
CMS lists C9047’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9047
All C codesC9041Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mgC9042Injection, bendamustine hcl (belrapzo), 1 mgC9043Injection, levoleucovorin, 1 mgC9044Injection, cemiplimab-rwlc, 1 mgC9045Injection, moxetumomab pasudotox-tdfk, 0.01 mgC9046Cocaine hydrochloride nasal solution (goprelto), 1 mgC9048Dexamethasone, lacrimal ophthalmic insert, 0.1 mgC9049Injection, tagraxofusp-erzs, 10 mcgC9050Injection, emapalumab-lzsg, 1 mgC9051Injection, omadacycline, 1 mgC9052Injection, ravulizumab-cwvz, 10 mgC9053Injection, crizanlizumab-tmca, 1 mg